Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+24.97%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$111B
AUM Growth
+$111B
Cap. Flow
-$1.83B
Cap. Flow %
-1.65%
Top 10 Hldgs %
40.37%
Holding
493
New
5
Increased
168
Reduced
170
Closed
39

Sector Composition

1 Consumer Discretionary 27.8%
2 Healthcare 22.38%
3 Technology 21.76%
4 Communication Services 11.88%
5 Financials 5.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
JKHY icon
401
Jack Henry & Associates
JKHY
$11.9B
$9.35K ﹤0.01% 62
LBRDK icon
402
Liberty Broadband Class C
LBRDK
$8.73B
$9.23K ﹤0.01% 113
RIO icon
403
Rio Tinto
RIO
$102B
$8.78K ﹤0.01% 128 +36 +39% +$2.47K
EGHT icon
404
8x8 Inc
EGHT
$270M
$8.53K ﹤0.01% 2,045
HI icon
405
Hillenbrand
HI
$1.79B
$8.08K ﹤0.01% 170
MRTX
406
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.96K ﹤0.01% 214
ACMR icon
407
ACM Research
ACMR
$1.81B
$7.72K ﹤0.01% 660
WSM icon
408
Williams-Sonoma
WSM
$23.1B
$7.67K ﹤0.01% 63
MATV icon
409
Mativ Holdings
MATV
$687M
$7.3K ﹤0.01% 340 +75 +28% +$1.61K
OM icon
410
Outset Medical
OM
$247M
$7.1K ﹤0.01% 386 +80 +26% +$1.47K
XPER icon
411
Xperi
XPER
$278M
$6.33K ﹤0.01% 579
FOLD icon
412
Amicus Therapeutics
FOLD
$2.34B
$5.97K ﹤0.01% 538
ZYXI icon
413
Zynex
ZYXI
$49.7M
$5.77K ﹤0.01% 481
ATEX icon
414
Anterix
ATEX
$445M
$5.35K ﹤0.01% 162
CSTL icon
415
Castle Biosciences
CSTL
$696M
$5.11K ﹤0.01% 225
LASR icon
416
nLIGHT
LASR
$1.44B
$4.76K ﹤0.01% 468
LSPD icon
417
Lightspeed Commerce
LSPD
$1.67B
$4.71K ﹤0.01% 310
NNDM
418
Nano Dimension
NNDM
$300M
$4.62K ﹤0.01% 1,600
RARE icon
419
Ultragenyx Pharmaceutical
RARE
$2.89B
$4.61K ﹤0.01% 115
DOMO icon
420
Domo
DOMO
$591M
$4.56K ﹤0.01% 321
LYFT icon
421
Lyft
LYFT
$6.73B
$4.52K ﹤0.01% 488 -600 -55% -$5.56K
SGMO icon
422
Sangamo Therapeutics
SGMO
$157M
$4.42K ﹤0.01% 2,510
CERS icon
423
Cerus
CERS
$251M
$4.33K ﹤0.01% 1,459
SCLX icon
424
Scilex Holding
SCLX
$124M
$4.29K ﹤0.01% +523 New +$4.29K
AGIO icon
425
Agios Pharmaceuticals
AGIO
$2.19B
$4.27K ﹤0.01% 186